Skip to main content

Large Scale Biology Q3 Revenues Plummet 58 Percent As 2003 Closure of Contract Proteomics Unit Takes Toll

NEW YORK , Nov. 4 (GenomeWeb News) - Large Scale Biology, owner of Predictive Diagnostics, today said that third-quarter revenue nosedived 58 percent, to $500,000 from $1.2 million one year ago.

The Vacaville, Calif.-based company did not break out figures for its wholly owned biomarker-company subsidiary.

 

LSB attributed the severe decline to the loss of $800,000 in revenues generated during the third quarter of 2003 by its Germantown, Md.-based contract proteomics business, which it closed last November ( see ProteoMonitor, GenomeWeb News' sister publication ).


The company spent $2.3 million on R&D in the period, down slightly from $2.7 million year over year.


Consequently, net losses for the third quarter narrowed to $4.2 million, or $.13 per share, from $4.3 million, or $.17 per share, in 2003.

 

The results do not include one full quarter of activity related to Predictive Diagnostics' agreement with PerkinElmer, which the companies announced in late September. Under the agreement, PerkinElmer will offer the Predictive Diagnostics' Biomarker Amplification Filter technology to complement its own prOTOF 2000 MALDI O-TOF mass spectrometer.


LSB ended the quarter with $3.9 million in cash and marketable securities.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.